1. Home
  2. ATYR vs AUDC Comparison

ATYR vs AUDC Comparison

Compare ATYR & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.74

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$8.93

Market Cap

267.0M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
AUDC
Founded
2005
1992
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Telecommunications Equipment
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
267.0M
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
ATYR
AUDC
Price
$0.74
$8.93
Analyst Decision
Buy
Buy
Analyst Count
6
3
Target Price
$8.75
$11.67
AVG Volume (30 Days)
2.1M
107.5K
Earning Date
11-06-2025
02-03-2026
Dividend Yield
N/A
4.51%
EPS Growth
N/A
15.76
EPS
N/A
0.46
Revenue
$190,000.00
$244,553,000.00
Revenue This Year
N/A
$2.52
Revenue Next Year
$18,728.88
$3.15
P/E Ratio
N/A
$19.08
Revenue Growth
N/A
0.15
52 Week Low
$0.64
$8.01
52 Week High
$7.29
$12.72

Technical Indicators

Market Signals
Indicator
ATYR
AUDC
Relative Strength Index (RSI) 43.06 48.60
Support Level $0.69 $8.79
Resistance Level $0.76 $9.20
Average True Range (ATR) 0.04 0.24
MACD 0.01 0.01
Stochastic Oscillator 29.82 48.10

Price Performance

Historical Comparison
ATYR
AUDC

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

Share on Social Networks: